NASDAQ

Enanta Pharmaceuticals, Inc. (ENTA)

♥ 591 Thanks from members

Live price chart, market sentiment, and community perspectives for Enanta Pharmaceuticals, Inc. (NASDAQ: ENTA).

Member Opinions and Insights

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →
Entity and Market Metadata
Sector: HealthcareIndustry: BiotechnologyFounder: Tim McCarthyFounder: Ganesh SambandamurthyLeadership: Supratik Dasgupta (CEO)Leadership: Gary Titus (CFO)Holder: FMR LLCHolder: BlackRock, Inc.GlecaprevirVibativEDP-235Antiviral pipeline drugs#ENTA stock#Enanta Pharmaceuticals#biotech sector#antiviral drugs#liver disease treatment